Research Article

A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network

Table 4

Breast cancer pathways from GSE2990 ().

#NameESNES value

1REACTOME_DEFENSINS−0.767−1.5990.008230452
2REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT0.7711.6680.004016064
3REACTOME_G0_AND_EARLY_G1−0.771−1.6010.008213553
4REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL−0.601−1.6700
5REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL0.7561.6440.00617284
6REACTOME_PECAM1_INTERACTIONS−0.855−1.6850.001972387
7REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION0.7731.5580.003891051
8REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX−0.773−1.6130.008438818
9BIOCARTA_GATA3_PATHWAY0.7461.6880.002004008
10REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE0.7091.7470
11BIOCARTA_G2_PATHWAY−0.705−1.7040.00625
12REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS−0.757−1.7180.001865672
13REACTOME_PYRIMIDINE_METABOLISM−0.702−1.7260.001964637
14BIOCARTA_ACTINY_PATHWAY−0.734−1.7490.001945525
15REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI0.7031.6990.001976285
16REACTOME_ENDOGENOUS_STEROLS−0.762−1.6940.005703422
17REACTOME_GLYCOSPHINGOLIPID_METABOLISM0.5901.7630.006048387

Supplementary files 2, 3, 4, and 5 provide the full pathway enrichment analysis results for the breast cancer expression profiles.